| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Hepion Pharmaceuticals Inc (NASDAQ: HEPA)
HEPA Technical Analysis
5
| As on 4th Feb 2025 HEPA STOCK Price closed @ 0.17 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.95 & Strong Sell for SHORT-TERM with Stoploss of 5.57 we also expect STOCK to react on Following IMPORTANT LEVELS. |
HEPASTOCK Price
| Open | 0.16 | Change | Price | % |
| High | 0.18 | 1 Day | 0.01 | 6.25 |
| Low | 0.16 | 1 Week | -0.02 | -10.53 |
| Close | 0.17 | 1 Month | -0.39 | -69.64 |
| Volume | 8309710 | 1 Year | -6.61 | -97.49 |
| 52 Week High 7.70 | 52 Week Low 0.14 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| NVDA | 118.65 | 1.71% |
| TNXP | 0.15 | -21.05% |
| LMDX | 0.02 | 0.00% |
| AKTS | 0.04 | 0.00% |
| BHAT | 0.04 | -20.00% |
| PONO | 1.72 | 2.38% |
| TELL | 1.00 | 0.00% |
| PLUG | 1.95 | 4.84% |
| LCID | 2.93 | 4.64% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| HEPA Daily Charts |
HEPA Intraday Charts |
Whats New @ Bazaartrend |
HEPA Free Analysis |
|
|
HEPA Important Levels Intraday
| RESISTANCE | 0.21 |
| RESISTANCE | 0.20 |
| RESISTANCE | 0.19 |
| RESISTANCE | 0.18 |
| SUPPORT | 0.16 |
| SUPPORT | 0.15 |
| SUPPORT | 0.14 |
| SUPPORT | 0.13 |
HEPA Forecast February 2025
| 4th UP Forecast | 6.61 |
| 3rd UP Forecast | 4.54 |
| 2nd UP Forecast | 3.27 |
| 1st UP Forecast | 1.99 |
| 1st DOWN Forecast | -1.65 |
| 2nd DOWN Forecast | -2.93 |
| 3rd DOWN Forecast | -4.2 |
| 4th DOWN Forecast | -6.27 |
HEPA Weekly Forecast
| 4th UP Forecast | 1.63 |
| 3rd UP Forecast | 1.16 |
| 2nd UP Forecast | 0.87 |
| 1st UP Forecast | 0.58 |
| 1st DOWN Forecast | -0.24 |
| 2nd DOWN Forecast | -0.53 |
| 3rd DOWN Forecast | -0.82 |
| 4th DOWN Forecast | -1.29 |
HEPA Forecast2025
| 4th UP Forecast | 15.07 |
| 3rd UP Forecast | 10.29 |
| 2nd UP Forecast | 7.34 |
| 1st UP Forecast | 4.38 |
| 1st DOWN Forecast | -4.04 |
| 2nd DOWN Forecast | -7 |
| 3rd DOWN Forecast | -9.95 |
| 4th DOWN Forecast | -14.73 |
Hepion Pharmaceuticals Inc ( NASDAQ USA Symbol : HEPA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
HEPA Business Profile
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing CRV431, a cyclophilin inhibitor that is in Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey. Address: 399 Thornall Street, Edison, NJ, United States, 08837
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service